Showing results (131-140 of 298) with videos related to
Sort By:
Pageof 30
European Journal of Heart Failure|January 3, 2019
Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF studyJoão Pedro Ferreira, Marco Metra, Stefan D Anker, et al.European Journal of Heart Failure|September 5, 2008
Design of the heart failure endpoint evaluation of AII-antagonist losartan (HEAAL) study in patients intolerant to ACE-inhibitorMarvin A Konstam, Philip A Poole-Wilson, Kenneth Dickstein, et al.European Journal of Heart Failure|February 17, 2015
The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF studyPiotr Ponikowski, Gerasimos Filippatos, Josep Comin Colet, et al.Nutrients|August 23, 2020
A Clinical Tool to Predict Low Serum Selenium in Patients with Worsening Heart FailureAli A Al-Mubarak, Niels Grote Beverborg, Stefan D Anker, et al.International Journal of Cardiology|October 11, 2012
Intravenous immunoglobulin does not reduce left ventricular remodeling in patients with myocardial dysfunction during hospitalization after acute myocardial infarctionLars Gullestad, Stein Orn, Kenneth Dickstein, et al.Lancet (London, England)|November 20, 2009
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trialMarvin A Konstam, James D Neaton, Kenneth Dickstein, et al.Journal of the American College of Cardiology|February 16, 2018
Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial FibrillationJoão Pedro Ferreira, Nicolas Girerd, John Gregson, et al.The New England Journal of Medicine|September 4, 2013
Cardiac-resynchronization therapy in heart failure with a narrow QRS complexFrank Ruschitzka, William T Abraham, Jagmeet P Singh, et al.Diabetes Care|July 11, 2022
Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker StudyHertzel C Gerstein, Sibylle Hess, Brian Claggett, et al.European Journal of Heart Failure|March 20, 2021
Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin-angiotensin-aldosterone system in patients with heart failureEva M Boorsma, Jozine M Ter Maaten, Kevin Damman, et al.Pageof 30